Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Lipigon Pharmaceuticals AB (publ)
  6. News
  7. Summary
    LPGO   SE0015382072

LIPIGON PHARMACEUTICALS AB (PUBL)

(LPGO)
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Lipigon Pharmaceuticals AB has completed an IPO in the amount of SEK 50.007395 million.

03/01/2021 | 12:00am EST

Lipigon Pharmaceuticals AB (publ) has completed an IPO in the amount of SEK 50.007395 million. Security Name: Units Security Type: Equity/Derivative Unit Securities Offered: 4,464,946 PriceRange: SEK 11.2 Transaction Features: Rights Offering


ę S&P Capital IQ 2021
All news about LIPIGON PHARMACEUTICALS AB (PUBL)
01/14Lipigon Pharmaceuticals AB Completes Another Preclinical Study with Drug Candidate Lipi..
CI
2021Lipigon Announces Positive Results from Preclinical Study for Lipid-Lowering Drug Candi..
CI
2021Lipigon Pharmaceuticals AB Reports Earnings Results for the Third Quarter and Nine Mont..
CI
2021Lipigon Pharmaceuticals AB and 5Prime Sciences Enter Partnership to Optimize Coming Cli..
CI
2021Lipigon Pharmaceuticals AB Publ Reports Earnings Results for the Second Quarter Ended J..
CI
2021Lipigon Pharmaceuticals AB cancelled the acquisition of antisense drug candidates and p..
CI
2021Lipigon Pharmaceuticals AB has completed an IPO in the amount of SEK 50.007395 million.
CI
2021Lipigon Pharmaceuticals AB has filed an IPO in the amount of SEK 50.007395 million.
CI
2020Lipigon Pharmaceuticals AB signed a research, development, and transfer agreement to ac..
CI
2016Lipigon Pharmaceuticals AB announced that it has received funding from Almi Invest AB
CI
More news
Financials
Sales 2020 4,01 M 0,43 M 0,43 M
Net income 2020 -8,07 M -0,86 M -0,86 M
Net cash 2020 12,6 M 1,33 M 1,33 M
P/E ratio 2020 -
Yield 2020 -
Capitalization 56,6 M 6,01 M 6,01 M
EV / Sales 2019 -
EV / Sales 2020 -
Nbr of Employees 6
Free-Float -
Chart LIPIGON PHARMACEUTICALS AB (PUBL)
Duration : Period :
Lipigon Pharmaceuticals AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Stefan Kristoffer Nilsson Chief Executive Officer
Michael Owens Chief Financial Officer
Urban Paulsson Chairman
Lars Ole Íhman Director, Deputy CEO & Head-Business Development
Ingrid Elisabet Olivecrona Director